Literature DB >> 23159043

Aβ amyloid, cognition, and APOE genotype in healthy older adults.

Yen Ying Lim1, Kathryn A Ellis, David Ames, David Darby, Karra Harrington, Ralph N Martins, Colin L Masters, Christopher Rowe, Greg Savage, Cassandra Szoeke, Victor L Villemagne, Paul Maruff.   

Abstract

BACKGROUND: Only one study has investigated the relationship between cerebral β-amyloid (Aβ), apolipoprotein E (APOE) ε4 genotype, and cognition. Although significant relationships between cerebral Aβ and cognition were observed in ε4 carriers but not noncarriers, the magnitude of this relationship was not reported. Further, when demographic variables were controlled, the influence of APOE ε4 on the relationship between cerebral Aβ and cognition dissipated.
METHODS: In 144 healthy older adults who had undergone amyloid scanning and APOE ε4 genotyping in the Australian Imaging, Biomarkers, and Lifestyle (AIBL) Flagship Study of Ageing, correlations were conducted to determine the magnitude of relationship between cerebral Aβ and cognition in ε4 carriers and noncarriers. Fisher's Z was used to compare these correlations and Cohen's q determined the magnitude of difference between correlations.
RESULTS: Cerebral Aβ was significantly associated with tasks of visual and verbal episodic memory in APOE ε4 carriers. This association was not observed in ε4 noncarriers. The relationship between cerebral Aβ and episodic memory in ε4 carriers was significantly different from that in ε4 noncarriers, and the magnitude of this difference was small to moderate.
CONCLUSIONS: In APOE ε 4 carriers, there is a moderate negative relationship between cerebral Aβ and episodic memory. This suggests that increased cerebral Aβ may signify the onset of preclinical AD, especially in healthy older adults who are genetically at risk for AD.
Copyright © 2013 The Alzheimer's Association. All rights reserved.

Entities:  

Keywords:  AIBL; APOE ɛ4; Cerebral Aβ burden; Episodic memory; Healthy older adults

Mesh:

Substances:

Year:  2012        PMID: 23159043     DOI: 10.1016/j.jalz.2012.07.004

Source DB:  PubMed          Journal:  Alzheimers Dement        ISSN: 1552-5260            Impact factor:   21.566


  28 in total

1.  Association of cerebrospinal fluid Aβ42 with A2M gene in cognitively normal subjects.

Authors:  Steven P Millard; Franziska Lutz; Ge Li; Douglas R Galasko; Martin R Farlow; Joseph F Quinn; Jeffrey A Kaye; James B Leverenz; Debby Tsuang; Chang-En Yu; Elaine R Peskind; Lynn M Bekris
Journal:  Neurobiol Aging       Date:  2013-09-04       Impact factor: 4.673

2.  Sleep Disturbance and the Risk of Cognitive Decline or Clinical Conversion in the ADNI Cohort.

Authors:  Adam P Mecca; Hannah R Michalak; Julia W McDonald; Emily C Kemp; Erika A Pugh; Melinda L Becker; Marcia C Mecca; Christopher H van Dyck
Journal:  Dement Geriatr Cogn Disord       Date:  2018-06-08       Impact factor: 2.959

3.  Independent comparison of CogState computerized testing and a standard cognitive battery with neuroimaging.

Authors:  Michelle M Mielke; Stephen D Weigand; Heather J Wiste; Prashanthi Vemuri; Mary M Machulda; Davis S Knopman; Val Lowe; Rosebud O Roberts; Kejal Kantarci; Walter A Rocca; Clifford R Jack; Ronald C Petersen
Journal:  Alzheimers Dement       Date:  2014-11-15       Impact factor: 21.566

4.  Sex, amyloid, and APOE ε4 and risk of cognitive decline in preclinical Alzheimer's disease: Findings from three well-characterized cohorts.

Authors:  Rachel F Buckley; Elizabeth C Mormino; Rebecca E Amariglio; Michael J Properzi; Jennifer S Rabin; Yen Ying Lim; Kathryn V Papp; Heidi I L Jacobs; Samantha Burnham; Bernard J Hanseeuw; Vincent Doré; Annette Dobson; Colin L Masters; Michael Waller; Christopher C Rowe; Paul Maruff; Michael C Donohue; Dorene M Rentz; Dylan Kirn; Trey Hedden; Jasmeer Chhatwal; Aaron P Schultz; Keith A Johnson; Victor L Villemagne; Reisa A Sperling
Journal:  Alzheimers Dement       Date:  2018-05-24       Impact factor: 21.566

Review 5.  Molecular imaging of Alzheimer disease pathology.

Authors:  K Kantarci
Journal:  AJNR Am J Neuroradiol       Date:  2014-02-06       Impact factor: 3.825

Review 6.  Imaging brain effects of APOE4 in cognitively normal individuals across the lifespan.

Authors:  Marine Fouquet; Florent L Besson; Julie Gonneaud; Renaud La Joie; Gaël Chételat
Journal:  Neuropsychol Rev       Date:  2014-08-22       Impact factor: 7.444

7.  Genetic resilience to amyloid related cognitive decline.

Authors:  Timothy J Hohman; Logan Dumitrescu; Nancy J Cox; Angela L Jefferson
Journal:  Brain Imaging Behav       Date:  2017-04       Impact factor: 3.978

8.  Computerized Cognitive Testing for Use in Clinical Trials: A Comparison of the NIH Toolbox and Cogstate C3 Batteries.

Authors:  R F Buckley; K P Sparks; K V Papp; M Dekhtyar; C Martin; S Burnham; R A Sperling; D M Rentz
Journal:  J Prev Alzheimers Dis       Date:  2017

9.  Cortical β-amyloid burden, gray matter, and memory in adults at varying APOE ε4 risk for Alzheimer's disease.

Authors:  Adam P Mecca; Nicole M Barcelos; Shuo Wang; Anna Brück; Nabeel Nabulsi; Beata Planeta-Wilson; Jennifer Nadelmann; Amanda L Benincasa; Jim Ropchan; Yiyun Huang; Joel Gelernter; Peter H Van Ness; Richard E Carson; Christopher H van Dyck
Journal:  Neurobiol Aging       Date:  2017-10-06       Impact factor: 4.673

10.  A pilot study of neuropsychological functions, APOE and amyloid imaging in patients with gliomas.

Authors:  D D Correa; M Kryza-Lacombe; X Zhou; R E Baser; B J Beattie; Z Beiene; J Humm; L M DeAngelis; I Orlow; W Weber; J Osborne
Journal:  J Neurooncol       Date:  2017-11-22       Impact factor: 4.130

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.